Pitavastatin lowers risk of cardiovascular events in people living with HIV
Top 5 HIV treatment stories from CROI 2023
Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment
Switching from TAF to older tenofovir may halt or reverse weight gain and lipid increases
People with HIV not getting medication to prevent heart disease, despite high risk
High rate of new peripheral artery disease cases in people with HIV
Integrase inhibitors raise the risk of heart attack, stroke during first two years of treatment
Fatty liver disease raises the risk of cardiovascular disease in people with HIV
People with HIV more likely to develop high blood pressure after starting an integrase inhibitor
